BioTactics in Action: Start Page

Vol. 1, Issue 5
October 1998 

Home
Index of Issues
Site Map
Contact Us

Subscribe/
Unsubscribe

Online Newsletter for
Biotech Marketing and Business Development

Please visit our sponsor: Market Value Concepts

border.gif (871 bytes) Marketing Research Products to Molecular Pathologists, p 3.
by Mike Klein, Clinical Marketing Consultants
wpe33.jpg (866 bytes)

wpe33.jpg (866 bytes)

Recommendations of Scientific Societies and Taskforces

American scientific and medical societies issue policy statements which address concerns within the organizations. Often the statements include blanket recommendations that may positively or negatively affect the proliferation of molecular diagnostic procedures.

For example, in November of 1989, soon after the discovery of the gene for cystic fibrosis, the American Society of Human Genetics issued a statement recommending genetic testing for individuals with a family history of CF. However, in that same statement, the ASHG considered screening of the general population to be premature, citing inadequacies in the accuracy of the test and calling for establishment of centralized quality control for testing laboratories.

Three years later, the Society released a second statement, still recommending against screening of the populace. However, in May of 1997, the National Institutes of Health issued a policy statement recommending that CF carrier testing be offered to all pregnant women. As a result, CF screening could become the standard, with physicians that fail to offer the test to a pregnant woman legally liable if the mother gives birth to an affected child.

The ramifications of such policy statements are enormous. If testing for CF and other inherited diseases becomes the standard for all pregnancies, a significant increase on expenditures on the appropriate molecular biology reagents would be realized. Most scientific societies maintain a presence on the worldwide web and issue public releases of policy statements. Careful monitoring of societal recommendations can enable reagent manufacturers to effectively react to important changes in the molecular diagnostic marketplace.

Government Regulation of Homebrew Procedures

Molecular diagnostic tests can be divided into two categories:

  • Tests offered as a service by a licensed diagnostic laboratory that incorporate research products and homemade reagents into diagnostic protocols.
  • Diagnostic kits that have been approved by the Food and Drug Administration (FDA) for diagnostic applications.


newsline.jpg (2561 bytes)

| Back | MVC | Home | Email | Discussion | Site Map | Tips | Top of Page | Forward |
| Career | Planning Tools | Network | News | Calendar | Travel | Partners |

BioTactics Reference Web for Marketing and Business Development in Biotech
Sponsored by Market Value Concepts. © Copyright 1997,1998, 1999 Market Value Concepts.
BioTactics and BioTactics in Action are Trademarks of Market Value Concepts.
http://www.biotactics.com/Newsletter/v1i5/Molbio3.htm